Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Opinion in Pharmacology|July 11, 2018
Advanced cellular systems to study tuberculosis treatmentMagdalena K Bielecka, Paul ElkingtonAntibiotics (Basel, Switzerland)|October 27, 2022
Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human TuberculosisXimena Gonzalo, Magdalena K Bielecka, Liku Tezera, et al.Mbio|February 9, 2017
A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in TuberculosisMagdalena K Bielecka, Liku B Tezera, Robert Zmijan, et al.Bio-Protocol|September 15, 2017
Bioelectrospray Methodology for Dissection of the Host-pathogen Interaction in Human TuberculosisLiku B Tezera, Magdalena K Bielecka, Paul T ElkingtonThe Journal of Infection|May 11, 2020
WITHDRAWN: Personal respirators for population level control of the COVID19 pandemicPaul Elkington, Hywel MorganTrends in Immunology|November 7, 2016
Tuberculosis: An Infection-Initiated Autoimmune Disease?Paul Elkington, Marc Tebruegge, Salah MansourOcular Immunology and Inflammation|May 15, 2020
Animal Models of Ocular Tuberculosis: Implications for Diagnosis and TreatmentSoumyava Basu, Narsing Rao, Paul ElkingtonScience Advances|September 6, 2023
<i>Shigella</i> induces epigenetic reprogramming of zebrafish neutrophilsMargarida C Gomes, Dominik Brokatzky, Magdalena K Bielecka, et al.Tuberculosis (Edinburgh, Scotland)|October 4, 2020
Pathogenesis of ocular tuberculosis: New observations and future directionsSoumyava Basu, Paul Elkington, Narsing A RaoCurrent Opinion in Microbiology|March 11, 2011
Regulation of Listeria virulence: PrfA master and commanderAitor de las Heras, Robert J Cain, Magdalena K Bielecka, et al.Pageof 5